Nov 13, 2017 21:30 pm UTC| Business
PLANTATION, Fla., Nov. 13, 2017 -- TradeStation, a Monex Group company and award-winning* online broker-dealer and futures commission merchant, today announced plans to offer its futures clients the ability to trade new...
CarTech® Puris™ 5+ Titanium Powder Shows Promising Results
Nov 13, 2017 21:30 pm UTC| Business
PHILADELPHIA, Nov. 13, 2017 -- Carpenter Technology Corporation (NYSE:CRS) announced today that its Carpenter Powder Products (CPP) business has recently released new data from testing of its CarTech Puris 5+ titanium...
InterDigital Issues Revenue Guidance for Fourth Quarter 2017
Nov 13, 2017 21:30 pm UTC| Business
WILMINGTON, Del., Nov. 13, 2017 -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that it expects its total fourth quarter 2017 revenue to be between $155 million...
Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference
Nov 13, 2017 21:30 pm UTC| Business
ANN ARBOR, Mich., Nov. 13, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Northern Power Systems Reports Third Quarter 2017 Results
Nov 13, 2017 21:30 pm UTC| Business
Business Highlights: Sustained growth leading to an 800-unit global installed fleet of distributed wind turbines, achieving almost 18 million run-time hours while delivering continued 98% grid-connected...
Mesoblast to Host First Quarter Financial Results Webcast and Conference Call
Nov 13, 2017 21:30 pm UTC| Business
NEW YORK and MELBOURNE, Australia, Nov. 13, 2017 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB;) today announced it will report financial results for the first quarter ended September 30, 2017 and provide a corporate...
Clearside Biomedical, Inc. to Participate in Stifel 2017 Healthcare Conference
Nov 13, 2017 21:30 pm UTC| Business
ALPHARETTA, Ga., Nov. 13, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced today...
FxWirePro- Major Economic Events for the day